BSX Income Statement
Boston Scientific Corp - Revenue, Expenses & Profit Analysis
Stock Price
$0.00
Market Cap
-
Most Recent Quarter
Period: 2024-12-31(2024-12-31)
Revenue
Total sales from operations
$16.75B
+17.6% YoY
Net Income
Bottom line profit
$1.85B
Earnings Per Share (Diluted)
Net income per share
$1.25
Profitability Metrics
Historical Income Statements
| Period | Revenue | Gross Profit | Operating Income | Net Income | EPS |
|---|---|---|---|---|---|
| 2024-12-31 | $16.75B | - | - | $1.85B | $1.25 |
| 2023-12-31 | $14.24B | - | - | $1.59B | $1.07 |
| 2022-12-31 | $12.68B | - | - | $698.00M | $0.45 |
| 2021-12-31 | $11.89B | - | - | $1.04B | $0.69 |
| 2020-12-31 | $9.91B | - | - | $-82.00M | $-0.08 |
View Complete Financial Analysis
Full income statements, balance sheets, cash flows, and AI-powered insights
Open Full AnalysisFrequently Asked Questions
What is BSX's revenue?
BSX's most recent quarterly revenue was $16.75B, representing a growth of 17.6% year-over-year.
Is BSX profitable?
BSX reported a profit of $1.85B in the most recent quarter.
What is BSX's operating income?
Operating income data is available in the income statement.
What is BSX's earnings per share (EPS)?
BSX reported diluted earnings per share of $1.25 in the most recent quarter.
What is BSX's gross profit margin?
Gross margin data is available in the profitability metrics section.